VeriMomcocamidopropyl pg-dimonium chloride phosphate est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (no H360/H361) is documented for this ingredient in ECHA Annex VI, and there are no SCCS or CIR safety opinions identifying reproductive hazard. No peer‑reviewed reproductive or developmental toxicity data specifically implicating this ingredient were identified in the literature. Dermal cosmetic use implies low but measurable exposure rather than negligible (typical for topically applied surfactants/quaternary salts). Sources consulted: ECHA C&L/Annex VI (no harmonised classification), PubMed (no reproductive/developmental studies found), PubChem/CosIng/EWG (no reproductive flags).
Pregnancy-safe products containing cocamidopropyl pg-dimonium chloride phosphate
Related ingredients
Frequently asked questions
- cocamidopropyl pg-dimonium chloride phosphate est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (no H360/H361) is documented for this ingredient in ECHA Annex VI, and there are no SCCS or CIR safety opinions identifying reproductive hazard. No peer‑reviewed reproductive or developmental toxicity data specifically implicating this ingredient were identified in the literature. Dermal cosmetic use implies low but measurable exposure rather than negligible (typical for topically applied surfactants/quaternary salts). Sources consulted: ECHA C&L/Annex VI (no harmonised classification), PubMed (no reproductive/developmental studies found), PubChem/CosIng/EWG (no reproductive flags).
- cocamidopropyl pg-dimonium chloride phosphate est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no evidence of reproductive or lactation-specific toxicity in authoritative sources, and no mechanistic data indicating mammary transfer. Topical use implies low but measurable exposure; therefore breastfeeding exposure considered low.
- cocamidopropyl pg-dimonium chloride phosphate est-il sûr pour la peau de bébé ?
- No infant‑specific hazard data identified. Because infant skin (0–3 yr) has a higher surface‑area‑to‑weight ratio and a less mature barrier, exposure score is increased by +1 versus adult (low → moderate). No evidence was found that infant exposure leads to systemic reproductive/mechanistic effects.
- Comment VeriMom évalue-t-il cocamidopropyl pg-dimonium chloride phosphate ?
- VeriMom évalue cocamidopropyl pg-dimonium chloride phosphate à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à cocamidopropyl pg-dimonium chloride phosphate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à cocamidopropyl pg-dimonium chloride phosphate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.